Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

Novartis Investigative Site, North Sydney

Novartis Investigative Site, Melbourne

Novartis Investigative Site, Greenslopes

Novartis Investigative Site, Marseille

Novartis Investigative Site, Pittsburgh

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Kiel

Novartis Investigative Site, Chapel Hill

Novartis Investigative Site, Madrid

Novartis Investigative Site, Málaga

Novartis Investigative Site, Atlanta

Novartis Investigative Site, Atlanta

Novartis Investigative Site, Hanover

Novartis Investigative Site, Pamplona

Novartis Investigative Site, Toulouse

Novartis Investigative Site, Montpellier

Novartis Investigative Site, Las Palmas de Gran Canaria

Novartis Investigative Site, Rennes

Novartis Investigative Site, Padua

Novartis Investigative Site, Birmingham

Novartis Investigative Site, Nashville

Novartis Investigative Site, Columbus

Novartis Investigative Site, Nantes

Novartis Investigative Site, Valencia

Novartis Investigative Site, Zaragoza

Novartis Investigative Site, Cologne

Novartis Investigative Site, Lille

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Pierre-Bénite

Novartis Investigative Site, Tübingen

Novartis Investigative Site, Paris

Novartis Investigative Site, Houston

Novartis Investigative Site, Aurora

Novartis Investigative Site, Munich

Novartis Investigative Site, Poitiers

Novartis Investigative Site, Boulogne-Billancourt

Novartis Investigative Site, San Francisco

Novartis Investigative Site, Villejuif

Novartis Investigative Site, Boston

Novartis Investigative Site, Edmonton

Novartis Investigative Site, Hamilton

Novartis Investigative Site, Toronto

Novartis Investigative Site, Montreal

Novartis Investigative Site, Gera

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Palma de Mallorca